Myanmar vs Saudi Arabia: Protecting minority investors: Ease of shareholder suits index (0-10)
Myanmar
40
in 2013
Saudi Arabia
40
in 2013
Myanmar rank
132nd
Saudi Arabia rank
132nd
Protecting minority investors: Ease of shareholder suits index (0-10) over time
- Myanmar
- Saudi Arabia
How they compare
Myanmar currently reports 40 against 40 in Saudi Arabia, a difference of 0.
The two have swapped places 1 time across 9 shared years of data; in 2005 it was Myanmar ahead.
Myanmar ranks 132nd and Saudi Arabia ranks 132nd of 191 countries.
Myanmar has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Myanmar | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 40 | 34 | 6 | Myanmar |
| 2010s | 40 | 40 | 0 | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher protecting minority investors: ease of shareholder suits index (0-10), Myanmar or Saudi Arabia?
- Myanmar, at 40 against 40 in Saudi Arabia as of 2013.
- What is the difference in protecting minority investors: ease of shareholder suits index (0-10) between Myanmar and Saudi Arabia?
- 0, with Myanmar ahead.
- How many years of comparable data are there for Myanmar and Saudi Arabia?
- 9 years are reported by both, from 2005 to 2013.
- How do Myanmar and Saudi Arabia rank globally for protecting minority investors: ease of shareholder suits index (0-10)?
- Myanmar ranks 132nd and Saudi Arabia ranks 132nd of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Ease of shareholder suits index (0-10) (DB06-14 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for ease of shareholder suits index benchmarks economies with respect to the regulatory best practice on the indicator. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB06-14 studies.